PL4514359T3 - Nowe formulacjedutogliptyny oraz sposób ich wytwarzania - Google Patents

Nowe formulacjedutogliptyny oraz sposób ich wytwarzania

Info

Publication number
PL4514359T3
PL4514359T3 PL23725087.3T PL23725087T PL4514359T3 PL 4514359 T3 PL4514359 T3 PL 4514359T3 PL 23725087 T PL23725087 T PL 23725087T PL 4514359 T3 PL4514359 T3 PL 4514359T3
Authority
PL
Poland
Prior art keywords
dutogliptin
formulations
novel
preparation
novel dutogliptin
Prior art date
Application number
PL23725087.3T
Other languages
English (en)
Inventor
Andreas SCHÜTZ
Original Assignee
Recardio Inc.
Project Pharmaceutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recardio Inc., Project Pharmaceutics Gmbh filed Critical Recardio Inc.
Publication of PL4514359T3 publication Critical patent/PL4514359T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PL23725087.3T 2022-04-26 2023-04-25 Nowe formulacjedutogliptyny oraz sposób ich wytwarzania PL4514359T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22170010 2022-04-26
PCT/EP2023/060716 WO2023208876A1 (en) 2022-04-26 2023-04-25 Novel dutogliptin formulations and their preparation

Publications (1)

Publication Number Publication Date
PL4514359T3 true PL4514359T3 (pl) 2025-08-11

Family

ID=81386935

Family Applications (1)

Application Number Title Priority Date Filing Date
PL23725087.3T PL4514359T3 (pl) 2022-04-26 2023-04-25 Nowe formulacjedutogliptyny oraz sposób ich wytwarzania

Country Status (13)

Country Link
US (1) US20250295680A1 (pl)
EP (1) EP4514359B1 (pl)
JP (1) JP2025515490A (pl)
KR (1) KR20250005383A (pl)
CN (1) CN119486716A (pl)
AU (1) AU2023260608A1 (pl)
CA (1) CA3250662A1 (pl)
DK (1) DK4514359T3 (pl)
ES (1) ES3036480T3 (pl)
HU (1) HUE071770T2 (pl)
MX (1) MX2024013139A (pl)
PL (1) PL4514359T3 (pl)
WO (1) WO2023208876A1 (pl)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100427064C (zh) * 2003-04-16 2008-10-22 沈阳药科大学 一种制备脂质体的新方法
BR112017018329A2 (pt) * 2015-02-27 2018-08-07 The Asan Foundation composição para prevenir ou tratar calcificação de válvula, contendo inibidor de dpp-4

Also Published As

Publication number Publication date
WO2023208876A1 (en) 2023-11-02
MX2024013139A (es) 2025-01-09
DK4514359T3 (da) 2025-07-21
US20250295680A1 (en) 2025-09-25
HUE071770T2 (hu) 2025-09-28
CA3250662A1 (en) 2023-11-02
CN119486716A (zh) 2025-02-18
AU2023260608A1 (en) 2024-10-31
JP2025515490A (ja) 2025-05-15
KR20250005383A (ko) 2025-01-09
ES3036480T3 (en) 2025-09-19
EP4514359A1 (en) 2025-03-05
EP4514359B1 (en) 2025-04-16

Similar Documents

Publication Publication Date Title
IL295102B2 (en) Formulations and their uses
IL290513A (en) Formulations of benzazepine conjugates and their use
IL291543A (en) Medical preparations and their use
IL313980A (en) The compositions containing the alpha-Factor Perro sequence and uses thereof
IL325595A (en) New compounds
GB202005282D0 (en) Pharmaceutical Formulations
ZA202210520B (en) Hydrogel compositions and preparation thereof
ZA202212663B (en) Pharmaceutical formulations
HUE071770T2 (hu) Új dutogliptin-készítmények és elõállításuk
ZA202408364B (en) Liquid-dispersible halopyruvate formulations and associated methods
PL4062913T3 (pl) Stały preparat doustny utidelonu
IL318702A (en) Compositions containing G-CSF and their uses
GB202204171D0 (en) Novel formulations
IL313482A (en) Stable formulations of SHR0302
GB202014921D0 (en) Tobacco compositions and preparation thereof
IL321617A (en) Formulations of bazuclatinib
GB202315863D0 (en) Formulations
GB202307059D0 (en) Formulations
GB202216961D0 (en) 5-meo-mt formulations
HK40072797A (en) Formulations and doses of pegylated uricase
CA3291419A1 (en) Oral formulations comprising avatrombopag and related uses
SI4531816T1 (sl) Farmacevtske formulacije biktegravirja in lenakapavirja
GB202212240D0 (en) New formulations and medical uses thereof
GB202314361D0 (en) Vaccine compositions and uses thereof
GB202105055D0 (en) Virucidal formulations and preparation thereof